Systemic sclerosis and hematopoietic transplantation

Category: Conditions & evidence · Editorial Review: Updated 20 October 2026 · 3 minute read

What research has tested

Systemic sclerosis can affect skin, blood vessels and internal organs. Clinical research has compared autologous hematopoietic transplantation with drug treatment in carefully selected severe disease. This approach includes intensive immune treatment followed by restoration of blood formation. The findings do not show that a simple outpatient infusion can reverse all forms of fibrosis.

Organ assessment drives safety

Heart, lung and kidney involvement are crucial to treatment decisions. The same organ disease that makes an effective therapy important can also increase the risks of intensive treatment. A rheumatology and transplantation team should explain the eligibility criteria and why a particular patient meets them. Skin symptoms alone are not enough to establish suitability.

Look for the correct service

A Korean consultation should be with a hospital program experienced in systemic sclerosis and intensive transplantation. Ask about collaboration between rheumatology, cardiology, pulmonary medicine and hematology. The relevant experience is care of patients with this disease and protocol, not the overall number of cosmetic or intravenous cell treatments a facility advertises.

Define realistic goals

Ask which outcomes are expected to improve and over what interval, how the disease will be tracked and what risks remain despite treatment. Bring lung testing, cardiac studies, kidney results and previous medication records. Discuss rehabilitation and symptom care alongside the transplant decision; these remain meaningful even when a disease-directed intervention is selected.

Continue exploring

• Acute myeloid leukemia and transplantation
• Acute lymphoblastic leukemia and transplantation
• Multiple myeloma and autologous transplant
• Prepare your consultation checklist

Sources & further reading

• Primary patient information and research

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.